The present invention relates to a novel preventive and/or therapeutic drug for myocardial infarction.The present invention provides a preventive and/or therapeutic drug for myocardial infarction or myocardial ischemia-reperfusion injury, the drug containing a lipid membrane structure retaining adenosine.